Singapore (PRWEB) October 7, 2008
Home-grown Sirius Medical Innovation ("SMI"), a specialist in thermal-imaging solutions, announced a first collaboration with Singapore's KK Women's and Children's Hospital ("KK Hospital") to conduct clinical trials of its Thermal Imaging Medical System ("TIMS"), which uses ultra-sensitive high-precision infrared thermal imaging cameras to detect breast cancer syndromes. This is the first such system in the world.
Supervised by KK Hospital's Head of Diagnostic Imaging, Prof. David A. Stringer, and his team of senior consultants, Phase I of the trials have been completed on more than 300 women patients, who have undergone diagnostic investigation for suspected breast cancer using TIMS, mammography, ultrasound and magnetic resonance imaging ("MRI"). Results from the Phase I trials have enabled the research team to calibrate the system effectively and develop best practices to facilitate future application of the technology.
"The initial batch of results have been encouraging, and should the trend continue, the clinical trial here in KK Hospital will serve as an important milestone in developing TIMS as an adjunctive medical diagnostic modality, which when used together with mammography, is expected to greatly heighten the likelihood of breast cancer detection," said Prof. David A. Stringer.
SMI and KK Hospital will now move to increase the number of women tested to another 1,000 in order to achieve the statistical significance necessary to validate the initial results. Upon successful completion of the trials, KK Hospital plans to offer TIMS as one of the various diagnostic services available for breast cancer detection at its KK Breast Centre - a one-stop medical centre located within KKH which is fully dedicated to looking after breast health.
"Seeing the potential in TIMS, we started to collaborate with SMI since early February to bring this new life-saving technology to the forefront of breast cancer research and treatment. We have since achieved several major research milestones in terms of calibrating the system and setting up best standards and processes to facilitate future training of medical professionals and institutions in the use of TIMS," said Prof Stringer.
Mr Jesse Hong, Managing Director of SMI, said, "KK Hospital is recognized for its commitment and expertise in breast cancer detection and treatment and we are proud to be able to work with such a reputable partner in bringing this life-saving technology to Singapore and eventually, to the region."
About KK Women's & Children's Hospital:
KK Women's and Children's Hospital (KKH) is the largest medical facility in Singapore which provides specialized care for women, babies and children. It is also the only women's and children's hospital in Southeast Asia to be accredited by the Joint Commission International body so far.
Since its inception in 1924, KKH has grown from a 30-bed maternity hospital into an 830-bed hospital. The hospital offers a full range of tertiary services for women in Obstetrics & Gynecology, Breast, Aesthetics, Otolaryngology and Orthopedics, as well as Neonatology and Pediatrics, through its 300 medical specialists combined with some of the most advanced medical technology and innovative equipment. KKH is committed to providing quality care, equipped with advanced diagnostic and treatment technology for the benefit of patients. (http://www.kkh.com.sg)
About SIRIUS Medical Innovation:
SIRIUS Medical Innovation (SMI), a subsidiary of Singapore Exchange-listed Jurong Technologies Corpn Ltd, is an innovative provider of thermal related equipments and solutions for the medical industry. Its fully integrated solutions enable the company to bring a product through idea conception and clinical research to final assembly and manufacturing. SMI is currently seeking to revolutionize the detection of breast cancer with its patented Thermal Imaging Medical System as an adjunctive procedure to mammography and ultrasound. (http://www.siriusdinnovation.com)
About the SingaporeMedicine Initiative:
Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as Asia's leading medical hub and international health care destination.
Led by the Ministry of Health of Singapore, SingaporeMedicine is supported by three government agencies: the Economic Development Board, which develops industry capabilities, the International Enterprise Singapore, which fosters regionalism by Singapore-based health care players, and the Singapore Tourism Board, which markets Singapore as a healthcare destination to inbound international patients and develops associated people-oriented services. (http://www.singaporemedicine.com)